-
Competing-risks model for prediction of small-for-gestational-age neonates from estimated fetal weight at 19-24 weeks' gestation.
Papastefanou I, Nowacka U, Syngelaki A, Dragoi V, Karamanis G, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2021;57:917-924. pdf -
Routine ultrasound at 32 vs 36 weeks' gestation: prediction of small-for-gestational-age neonates.
Ciobanu A, Khan N, Syngelaki A, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:761-768. pdf -
Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 20 and 36 weeks.
Ciobanu A, Formuso C, Syngelaki A, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:488-495. pdf -
Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks.
Ciobanu A, Anthoulakis C, Syngelaki A, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:630-637. pdf -
Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction.
Roberts LA, Ling HZ, Poon LC, Nicolaides KH, Kametas NA.
Ultrasound Obstet Gynecol 2018;52:507-514. pdf -
Chronic hypertension and adverse pregnancy outcomes: a cohort study.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:228-235. pdf -
Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:203-9. pdf -
Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:194-202. pdf -
Prediction of small-for-gestational-age neonates: screening by fetal biometry at 35-37 weeks.
Fadigas C, Saiid Y, Gonzalez R, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:559-65. pdf -
Prediction of small-for-gestational-age neonates: screening by fetal biometry at 30-34 weeks.
Bakalis S, Silva M, Akolekar R, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:551-8. pdf -
Prediction of small-for-gestational-age neonates: screening by fetal biometry at 19-24 weeks.
Lesmes C, Gallo DM, Panaiotova J, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;46:198-207. pdf -
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Bujold E, Roberge S, Nicolaides KH.
Prenat Diagn 2014;34:642-8. pdf -
Maternal racial origin and adverse pregnancy outcome: a cohort study.
Khalil A, Rezende J, Akolekar R, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:278-85. -
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH.
Prenat Diagn 2005;25:949-53. -
The role of uterine artery Doppler in predicting adverse pregnancy outcome.
Papageorghiou AT, Yu CK, Nicolaides KH.
Best Pract Res Clin Obstet Gynaecol 2004;18:383-96. -
Second-trimester uterine artery Doppler screening in unselected populations: a review.
Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;12:78-88. -
Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks.
Lees C, Parra M, Missfelder-Lobos H, Morgans A, Fletcher O, Nicolaides KH.
Obstet Gynecol 2001;98:369-73. -
One-stage screening for pregnancy complications by color doppler assessment of the uterine arteries at 23 weeks' gestation.
Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH.
Obstet Gynecol 2000;96:559-64.